showed that introduction of GBM‐associated mutations in tumor suppressors (tumor protein p53 [TP53]/neurofibromatosis type 1 [NF1]/phosphatase and tensin homolog [PTEN] or TP53/NF1) into human NSCs generates CSC populations and induces brain tumors. This evidence concerns the gene TP53 and glioblastoma.